Corrigendum to "'Conditioning' the heart during surgery" [Eur. J. Cardiothorac. Surg. 35 (6) (2009) 977-987] (DOI:10.1016/j.ejcts.2009.02.014);'Conditioning' the heart during surgery

European Journal of Cardio-thoracic Surgery

Volumn 35, Issue 6, 2009, Pages 977-987

  Venugopal, Vinod ^a   Ludman, Andrew ^a   Yellon, Derek M ^a   Hausenloy, Derek J ^a  

^a UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

Author keywords

Cardioplegia; Cardioprotection; Intermittent cross clamp fibrillation; Ischaemic postconditioning; Ischaemic preconditioning; Pharmacological preconditioning; Remote ischaemic preconditioning

Indexed keywords

5 AMINO 4 IMIDAZOLECARBOXAMIDE RIBOSIDE; ADENOSINE; ADENOSINE RECEPTOR STIMULATING AGENT; BRADYKININ; CARIPORIDE; DIAZOXIDE; GR 79236X; INHALATION ANESTHETIC AGENT; LEVOSIMENDAN; PEXELIZUMAB; TROPONIN I; TROPONIN T; UNCLASSIFIED DRUG;

CARDIOPLEGIA; CORONARY ARTERY BYPASS GRAFT; CROSS CLAMP FIBRILLATION; EXTRACORPOREAL CIRCULATION; HEART MUSCLE INJURY; HEART PROTECTION; HEART SURGERY; HUMAN; INDUCED HYPOTHERMIA; ISCHEMIC HEART DISEASE; ISCHEMIC PRECONDITIONING; PRIORITY JOURNAL; REVIEW;

EID: 67349156377     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejcts.2009.06.012     Document Type: Erratum

References (130)

1. Biancari F, Kangasniemi OP, Mahar MA, Rasinaho E, Satomaa A, Tiozzo V, Niemela M, Lepojarvi M. Changing risk of patients undergoing coronary artery bypass surgery. Interact Cardiovasc Thorac Surg 2009;8:40-4.
2. Kathiresan S., Servoss S.J., Newell J.B., Trani D., MacGillivray T.E., Lewandrowski K., Lee-Lewandrowski E., and Januzzi Jr. J.L. Cardiac troponin T elevation after coronary artery bypass grafting is associated with increased one-year mortality. Am J Cardiol 94 (2004) 879-881
3. Ferguson Jr. T.B., Hammill B.G., Peterson E.D., DeLong E.R., and Grover F.L. A decade of change-risk profiles and outcomes for isolated coronary artery bypass grafting procedures, 1990-1999: a report from the STS National Database Committee and the Duke Clinical Research Institute. Society of Thoracic Surgeons. Ann Thorac Surg 73 (2002) 480-489
4. Hausenloy D.J., and Yellon D.M. The evolving story of "conditioning" to protect against acute myocardial ischaemia-reperfusion injury. Heart 93 (2007) 649-651
5. Gibbon Jr. J.H. Application of a mechanical heart and lung apparatus to cardiac surgery. Minn Med 37 (2008) 171-180
6. Cordell A.R. Milestones in the development of cardioplegia. Ann Thorac Surg 60 (1995) 793-796
7. Baker J.B., Bentall H.H., Dreyer B., and Melrose D.G. Arrest of isolated heart with potassium citrate. Lancet 273 (1957) 555-559
8. Brown Jr. I.W., Smith W.W., Young Jr. W.G., and Sealy W.C. Experimental and clinical studies of controlled hypothermia rapidly produced and corrected by a blood heat exchanger during extracorporeal circulation. J Thorac Surg 36 (1958) 497-505
9. Lucas S.K., Gardner T.J., Elmer E.B., Flaherty J.T., Bulkley B.H., and Gott V.L. Comparison of the effects of left ventricular distention during cardioplegic-induced ischemic arrest and ventricular fibrillation. Circulation 62 (1980) I42-I49
10. Cooley D.A., Reul G.J., and Wukasch D.C. Ischemic contracture of the heart: "stone heart". Am J Cardiol 29 (1972) 575-577
11. Bretschneider H.J. [Survival time and ruperative time of the heart in normothermia and hypothermia]. Verh Dtsch Ges Kreislaufforsch 30 (1964) 11-34
12. Gay Jr. W.A., and Ebert P.A. Functional, metabolic, and morphologic effects of potassium-induced cardioplegia. Surgery 74 (1973) 284-290
13. Roe B.B., Hutchinson J.C., Fishman N.H., Ullyot D.J., and Smith D.L. Myocardial protection with cold, ischemic, potassium-induced cardioplegia. J Thorac Cardiovasc Surg 73 (1977) 366-374
14. Hearse D.J., Stewart D.A., and Braimbridge M.V. Cellular protection during myocardial ischemia: the development and characterization of a procedure for the induction of reversible ischemic arrest. Circulation 54 (1976) 193-202
15. Rosenkranz E.R. Substrate enhancement of cardioplegic solution: experimental studies and clinical evaluation. Ann Thorac Surg 60 (1995) 797-800
16. Hearse D.J. Cardioplegia: the protection of the myocardium during open heart surgery: a review. J Physiol (Paris) 76 (1980) 751-768
17. Follette D.M., Fey K.H., Steed D.L., Foglia R.P., and Buckberg G.D. Reducing reperfusion injury with hypocalcemic, hyperkalemic, alkalotic blood during reoxygenation. Surg Forum 29 (1978) 284-286
18. Buckberg G.D. A proposed "solution" to the cardioplegic controversy. J Thorac Cardiovasc Surg 77 (1979) 803-815
19. Mauney M.C., and Kron I.L. The physiologic basis of warm cardioplegia. Ann Thorac Surg 60 (1995) 819-823
20. Teoh K.H., Christakis G.T., Weisel R.D., Fremes S.E., Mickle D.A., Romaschin A.D., Harding R.S., Ivanov J., Madonik M.M., and Ross I.M. Accelerated myocardial metabolic recovery with terminal warm blood cardioplegia. J Thorac Cardiovasc Surg 91 (1986) 888-895
21. Franke U., Wahlers T., Cohnert T.U., Koenig J., Rath N.F., Wirsing M., and Haverich A. Retrograde versus antegrade crystalloid cardioplegia in coronary surgery: value of troponin-I measurement. Ann Thorac Surg 71 (2001) 249-253
22. Karthik S., Grayson A.D., Oo A.Y., and Fabri B.M. A survey of current myocardial protection practices during coronary artery bypass grafting. Ann R Coll Surg Engl 86 (2004) 413-415
23. Alhan H.C., Karabulut H., Tosun R., Karakoc F., Okar I., Demiray E., Tarcan S., and Yigiter B. Intermittent aortic cross-clamping and cold crystalloid cardioplegia for low-risk coronary patients. Ann Thorac Surg 61 (1996) 834-839
24. Liu Z., Valencia O., Treasure T., and Murday A.J. Cold blood cardioplegia or intermittent cross-clamping in coronary artery bypass grafting?. Ann Thorac Surg 66 (1998) 462-465
25. Teoh L.K., Grant R., Hulf J.A., Pugsley W.B., and Yellon D.M. A comparison between ischemic preconditioning, intermittent cross-clamp fibrillation and cold crystalloid cardioplegia for myocardial protection during coronary artery bypass graft surgery. Cardiovasc Surg 10 (2002) 251-255
26. Koppula A.S., Jagannath B.R., Balakrishnan K.R., and Gupta C.M. Noncardioplegic myocardial protection for CABG deserves a second look. Ann Thorac Surg 63 (1997) 914-915
27. Mack M.J., and Duhaylongsod F.G. Through the open door! Where has the ride taken us?. J Thorac Cardiovasc Surg 124 (2002) 655-659
28. Izzat M.B., West R.R., Bryan A.J., and Angelini G.D. Coronary artery bypass surgery: current practice in the United Kingdom. Br Heart J 71 (1994) 382-385
29. Kobayashi J. Current status of coronary artery bypass grafting. Gen Thorac Cardiovasc Surg 56 (2008) 260-267
30. Wheatley D.J. Protecting the damaged heart during coronary surgery. Heart 89 (2003) 367-368
31. Hottenrott C., and Buckberg G. Studies of the effects of ventricular fibrillation on the adequacy of regional myocardial flow. II. Effects of ventricular distention. J Thorac Cardiovasc Surg 68 (1974) 626-633
32. Anderson J.R., Hossein-Nia M., Kallis P., Pye M., Holt D.W., Murday A.J., and Treasure T. Comparison of two strategies for myocardial management during coronary artery operations. Ann Thorac Surg 58 (1994) 768-772
33. Taggart D.P., Bhusari S., Hopper J., Kemp M., Magee P., Wright J.E., and Walesby R. Intermittent ischaemic arrest and cardioplegia in coronary artery surgery: coming full circle?. Br Heart J 72 (1994) 136-139
34. Alex J., Ansari J., Guerrero R., Yogarathnam J., Cale A.R., Griffin S.C., Cowen M.E., and Guvendik L. Comparison of the immediate post-operative outcome of two different myocardial protection strategies: antegrade-retrograde cold St Thomas blood cardioplegia versus intermittent cross-clamp fibrillation. Interact Cardiovasc Thorac Surg 2 (2003) 584-588
35. Alwan K., Falcoz P.E., Alwan J., Mouawad W., Oujaimi G., Chocron S., and Etievent J.P. Beating versus arrested heart coronary revascularization: evaluation by cardiac troponin I release. Ann Thorac Sur 77 (2004) 2051-2055
36. Elahi M.M., and Khan J.S. Revascularization with off-pump coronary artery surgery: what appears new is actually the old rediscovered. Cardiovasc Revasc Med 8 (2007) 52-59
37. Gerola L.R., Buffolo E., Jasbik W., Botelho B., Bosco J., Brasil L.A., and Branco J.N. Off-pump versus on-pump myocardial revascularization in low-risk patients with one or two vessel disease: perioperative results in a multicenter randomized controlled trial. Ann Thorac Surg 77 (2004) 569-573
38. Nathoe H.M., van Dijk D., Jansen E.W., Suyker W.J., Diephuis J.C., van Boven W.J., de la Riviere A.B., Borst C., Kalkman C.J., Grobbee D.E., Buskens E., and de Jaegere P.P. A comparison of on-pump and off-pump coronary bypass surgery in low-risk patients. N Engl J Med 348 (2003) 394-402
39. Puskas J.D., Williams W.H., Mahoney E.M., Huber P.R., Block P.C., Duke P.G., Staples J.R., Glas K.E., Marshall J.J., Leimbach M.E., McCall S.A., Petersen R.J., Bailey D.E., Weintraub W.S., and Guyton R.A. Off-pump vs conventional coronary artery bypass grafting: early and 1-year graft patency, cost, and quality-of-life outcomes: a randomized trial. JAMA 291 (2004) 1841-1849
40. Bonchek L.I., Burlingame M.W., Vazales B.E., Lundy E.F., and Gassmann C.J. Applicability of noncardioplegic coronary bypass to high-risk patients. Selection of patients, technique, and clinical experience in 3000 patients. J Thorac Cardiovasc Surg 103 (1992) 230-237
41. Ascione R., Narayan P., Rogers C.A., Lim K.H., Capoun R., and Angelini G.D. Early and midterm clinical outcome in patients with severe left ventricular dysfunction undergoing coronary artery surgery. Ann Thorac Surg 76 (2003) 793-799
42. Chamberlain M.H., Ascione R., Reeves B.C., and Angelini G.D. Evaluation of the effectiveness of off-pump coronary artery bypass grafting in high-risk patients: an observational study. Ann Thorac Surg 73 (2002) 1866-1873
43. Lehrke S., Steen H., Sievers H.H., Peters H., Opitz A., Muller-Bardorff M., Wiegand U.K., Katus H.A., and Giannitsis E. Cardiac troponin T for prediction of short- and long-term morbidity and mortality after elective open heart surgery. Clin Chem 50 (2004) 1560-1567
44. Fellahi J.L., Gue X., Richomme X., Monier E., Guillou L., and Riou B. Short- and long-term prognostic value of postoperative cardiac troponin I concentration in patients undergoing coronary artery bypass grafting. Anesthesiology 99 (2003) 270-274
45. Brener S.J., Lytle B.W., Schneider J.P., Ellis S.G., and Topol E.J. Association between CK-MB elevation after percutaneous or surgical revascularization and three-year mortality. J Am Coll Cardiol 40 (2002) 1961-1967
46. Thygesen K., Alpert J.S., White H.D., Jaffe A.S., Apple F.S., Galvani M., Katus H.A., Newby L.K., Ravkilde J., Chaitman B., Clemmensen P.M., Dellborg M., Hod H., Porela P., Underwood R., Bax J.J., Beller G.A., Bonow R., Van der Wall E.E., Bassand J.P., Wijns W., Ferguson T.B., Steg P.G., Uretsky B.F., Williams D.O., Armstrong P.W., Antman E.M., Fox K.A., Hamm C.W., Ohman E.M., Simoons M.L., Poole-Wilson P.A., Gurfinkel E.P., Lopez-Sendon J.L., Pais P., Mendis S., Zhu J.R., Wallentin L.C., Fernandez-Aviles F., Fox K.M., Parkhomenko A.N., Priori S.G., Tendera M., Voipio-Pulkki L.M., Vahanian A., Camm A.J., De Caterina R., Dean V., Dickstein K., Filippatos G., Funck-Brentano C., Hellemans I., Kristensen S.D., McGregor K., Sechtem U., Silber S., Tendera M., Widimsky P., Zamorano J.L., Morais J., Brener S., Harrington R., Morrow D., Lim M., Martinez-Rios M.A., Steinhubl S., Levine G.N., Gibler W.B., Goff D., Tubaro M., Dudek D., and Al Attar N. Universal definition of myocardial infarction. Circulation 116 (2007) 2634-2653
47. Murry C.E., Jennings R.B., and Reimer K.A. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 74 (1986) 1124-1136
48. Yellon D.M., Alkhulaifi A.M., and Pugsley W.B. Preconditioning the human myocardium. Lancet 342 (1993) 276-277
49. Jenkins D.P., Pugsley W.B., Alkhulaifi A.M., Kemp M., Hooper J., and Yellon D.M. Ischaemic preconditioning reduces troponin T release in patients undergoing coronary artery bypass surgery. Heart 77 (1997) 314-318
50. Perrault L.P., Menasche P., Bel A., de Chaumaray T., Peynet J., Mondry A., Olivero P., Emanoil-Ravier R., and Moalic J.M. Ischemic preconditioning in cardiac surgery: a word of caution. J Thorac Cardiovasc Surg 112 (1996) 1378-1386
51. Cremer J., Steinhoff G., Karck M., Ahnsell T., Brandt M., Teebken O.E., Hollander D., and Haverich A. Ischemic preconditioning prior to myocardial protection with cold blood cardioplegia in coronary surgery. Eur J Cardiothorac Surg 12 (1997) 753-758
52. Kaukoranta P.K., Lepojarvi M.V., Kiviluoma K.T., Ylitalo K.V., and Peuhkurinen K.J. Myocardial protection during antegrade versus retrograde cardioplegia. Ann Thorac Surg 66 (1998) 755-761
53. Illes R.W., and Swoyer K.D. Prospective, randomized clinical study of ischemic preconditioning as an adjunct to intermittent cold blood cardioplegia. Ann Thorac Surg 65 (1998) 748-752
54. Li G., Chen S., Lu E., and Li Y. Ischemic preconditioning improves preservation with cold blood cardioplegia in valve replacement patients. Eur J Cardiothorac Surg 15 (1999) 653-657
55. Lu E.X., Chen S.X., Yuan M.D., Hu T.H., Zhou H.C., Luo W.J., Li G.H., and Xu L.M. Preconditioning improves myocardial preservation in patients undergoing open heart operations. Ann Thorac Surg 64 (1997) 1320-1324
56. Wu Z.K., Tarkka M.R., Pehkonen E., Kaukinen L., Honkonen E.L., and Kaukinen S. Ischaemic preconditioning has a beneficial effect on left ventricular haemodynamic function after a coronary artery bypass grafting operation. Scand Cardiovasc J 34 (2000) 247-253
57. Wu Z.K., Pehkonen E., Laurikka J., Kaukinen L., Honkonen E.L., Kaukinen S., and Tarkka M.R. Ischemic preconditioning protects right ventricular function in coronary artery bypass grafting patients experiencing angina within 48-72 hours. J Cardiovasc Surg (Torino) 43 (2002) 319-326
58. Wu Z.K., Iivainen T., Pehkonen E., Laurikka J., Zhang S., and Tarkka M.R. Fibrillation in patients subjected to coronary artery bypass grafting. J Thorac Cardiovasc Surg 126 (2003) 1477-1482
59. Wu Z.K., Iivainen T., Pehkonen E., Laurikka J., and Tarkka M.R. Ischemic preconditioning suppresses ventricular tachyarrhythmias after myocardial revascularization. Circulation 106 (2002) 3091-3096
60. Burns P.G., Krukenkamp I.B., Caldarone C.A., Gaudette G.R., Bukhari E.A., and Levitsky S. Does cardiopulmonary bypass alone elicit myoprotective preconditioning?. Circulation 92 (1995) II447-II451
61. Ghosh S., and Galinanes M. Protection of the human heart with ischemic preconditioning during cardiac surgery: role of cardiopulmonary bypass. J Thorac Cardiovasc Surg 126 (2003) 133-142
62. Gasz B., Lenard L., Racz B., Benko L., Borsiczky B., Cserepes B., Gal J., Jancso G., Lantos J., Ghosh S., Szabados S., Papp L., Alotti N., and Roth E. Effect of cardiopulmonary bypass on cytokine network and myocardial cytokine production. Clin Cardiol 29 (2006) 311-315
63. Walsh S.R., Tang T.Y., Kullar P., Jenkins D.P., Dutka D.P., and Gaunt M.E. Ischaemic preconditioning during cardiac surgery: systematic review and meta-analysis of perioperative outcomes in randomised clinical trials. Eur J Cardiothorac Surg 34 (2008) 985-994
64. Vaage J., and Valen G. Preconditioning and cardiac surgery. Ann Thorac Surg 75 (2003) S709-S714
65. Yellon D.M., and Downey J.M. Preconditioning the myocardium: from cellular physiology to clinical cardiology. Physiol Rev 83 (2003) 1113-1151
66. Hausenloy D.J., and Yellon D.M. Preconditioning and postconditioning: united at reperfusion. Pharmacol Ther 116 (2007) 173-191
67. Hausenloy D.J., and Yellon D.M. The mitochondrial permeability transition pore: its fundamental role in mediating cell death during ischaemia and reperfusion. J Mol Cell Cardiol 35 (2003) 339-341
68. Lee H.T., LaFaro R.J., and Reed G.E. Pretreatment of human myocardium with adenosine during open heart surgery. J Card Surg 10 (1995) 665-676
69. Zarro D.L., Palanzo D.A., and Sadr F.S. Myocardial preconditioning using adenosine: review and clinical experience. Perfusion 13 (1998) 145-150
70. Mentzer Jr. R.M., Rahko P.S., Molina-Viamonte V., Canver C.C., Chopra P.S., Love R.B., Cook T.D., Hegge J.O., and Lasley R.D. Safety, tolerance, and efficacy of adenosine as an additive to blood cardioplegia in humans during coronary artery bypass surgery. Am J Cardiol 79 (1997) 38-43
71. Teoh L.K., Grant R., Hulf J.A., Pugsley W.B., and Yellon D.M. The effect of preconditioning (ischemic and pharmacological) on myocardial necrosis following coronary artery bypass graft surgery. Cardiovasc Res 53 (2002) 175-180
72. Mangano D.T., Miao Y., Tudor I.C., and Dietzel C. Post-reperfusion myocardial infarction: long-term survival improvement using adenosine regulation with acadesine. J Am Coll Cardiol 48 (2006) 206-214
73. Wei M., Wang X., Kuukasjarvi P., Laurikka J., Rinne T., Honkonen E.L., and Tarkka M. Bradykinin preconditioning in coronary artery bypass grafting. Ann Thorac Surg 78 (2004) 492-497
74. Wang X., Wei M., Kuukasjarvi P., Laurikka J., Rinne T., Moilanen E., and Tarkka M. The anti-inflammatory effect of bradykinin preconditioning in coronary artery bypass grafting (bradykinin and preconditioning). Scand Cardiovasc J (2008) 1-8
75. Wang X., Wei M., Laurikka J., Kuukasjarvi P., Rinne T., Honkonen E.L., Nieminen R., Moilanen E., and Tarkka M. The anti-inflammatory effect of diazoxide in coronary artery bypass grafting. Shock 22 (2004) 23-28
76. Wang X., Wei M., Kuukasjarvi P., Laurikka J., Jarvinen O., Rinne T., Honkonen E.L., and Tarkka M. Novel pharmacological preconditioning with diazoxide attenuates myocardial stunning in coronary artery bypass grafting. Eur J Cardiothorac Surg 24 (2003) 967-973
77. Avkiran M., and Marber M.S. Na(+)/H(+) exchange inhibitors for cardioprotective therapy: progress, problems and prospects. J Am Coll Cardiol 39 (2002) 747-753
78. Boyce S.W., Bartels C., Bolli R., Chaitman B., Chen J.C., Chi E., Jessel A., Kereiakes D., Knight J., Thulin L., and Theroux P. Impact of sodium-hydrogen exchange inhibition by cariporide on death or myocardial infarction in high-risk CABG surgery patients: results of the CABG surgery cohort of the GUARDIAN study. J Thorac Cardiovasc Surg 126 (2003) 420-427
79. Mentzer Jr. R.M., Bartels C., Bolli R., Boyce S., Buckberg G.D., Chaitman B., Haverich A., Knight J., Menasche P., Myers M.L., Nicolau J., Simoons M., Thulin L., and Weisel R.D. Sodium-hydrogen exchange inhibition by cariporide to reduce the risk of ischemic cardiac events in patients undergoing coronary artery bypass grafting: results of the EXPEDITION study. Ann Thorac Surg 85 (2008) 1261-1270
80. Pollesello P., and Papp Z. The cardioprotective effects of levosimendan: preclinical and clinical evidence. J Cardiovasc Pharmacol 50 (2007) 257-263
81. Tritapepe L., De Santis V., Vitale D., Santulli M., Morelli A., Nofroni I., Puddu P.E., Singer M., and Pietrapaoli P. Preconditioning effects of levosimendan in coronary artery bypass grafting - a pilot study. Br J Anaesth 96 (2006) 694-700
82. Verrier E.D., Shernan S.K., Taylor K.M., Van De W.F., Newman M.F., Chen J.C., Carrier M., Haverich A., Malloy K.J., Adams P.X., Todaro T.G., Mojcik C.F., Rollins S.A., and Levy J.H. Terminal complement blockade with pexelizumab during coronary artery bypass graft surgery requiring cardiopulmonary bypass: a randomized trial. JAMA 291 (2004) 2319-2327
83. Piot C., Croisille P., Staat P., Thibault H., Rioufol G., Mewton N., Elbelghiti R., Cung T.T., Bonnefoy E., Angoulvant D., Macia C., Raczka F., Sportouch C., Gahide G., Finet G., Andre-Fouet X., Revel D., Kirkorian G., Monassier J.P., Derumeaux G., and Ovize M. Effect of cyclosporine on reperfusion injury in acute myocardial infarction. N Engl J Med 359 (2008) 473-481
84. Hausenloy D.J., and Yellon D.M. Time to take myocardial reperfusion injury seriously. N Engl J Med 359 (2008) 518-520
85. Toller W., Kersten J., and Pagel P. Sevoflurane reduces myocardial infarct size and decreases the time threshold for ischaemic preconditioning in dogs. Anesthesiology 91 (1999) 1437-1446
86. Raphael J., Abedat S., Rivo J., Meir K., Beeri R., Pugatsch T., Zuo Z., and Gozal Y. Volatile anesthetic preconditioning attenuates myocardial apoptosis in rabbits after regional ischemia and reperfusion via Akt signaling and modulation of Bcl-2 family proteins. J Pharmacol Exp Ther 318 (2006) 186-194
87. Obal D., Weber N.C., Zacharowski K., Toma O., Dettwiler S., Wolter J.I., Kratz M., Mullenheim J., Preckel B., and Schlack W. Role of protein kinase C-epsilon (PKCepsilon) in isoflurane-induced cardioprotection. Br J Anaesth 94 (2005) 166-173
88. Huhn R., Heinen A., Weber N.C., Hollmann M.W., Schlack W., and Preckel B. Hyperglycaemia blocks sevoflurane-induced postconditioning in the rat heart in vivo: cardioprotection can be restored by blocking the mitochondrial permeability transition pore. Br J Anaesth 100 (2008) 465-471
89. Novalija E., Varadarajan S.G., Camara A.K., An J., Chen Q., Riess M.L., Hogg N., and Stowe D.F. Anaesthetic preconditioning: triggering role of reactive oxygen and nitrogen species in isolated hearts. Am J Physiol Heart Circ Physiol 283 (2002) H44-H52
90. Piriou V., Chiari P., Gateau-Roesch O., Argaud L., Muntean D., Salles D., Loufouat J., Gueugniaud P.Y., Lehot J.J., and Ovize M. Desflurane-induced preconditioning alters calcium-induced mitochondrial permeability transition. Anesthesiology 100 (2004) 581-588
91. Tomai F., Danesi A., Ghini A.S., Crea F., Perino M., Gaspardone A., Ruggeri G., Chiariello L., and Gioffre P.A. Effects of K(ATP) channel blockade by glibenclamide on the warm-up phenomenon. Eur Heart J 20 (1999) 196-202
92. De Hert S., Cromheecke S., and ten Broecke P. Effects of propofol, desflurane, and sevoflurane on recovery of myocardial function after coronary surgery in elderly high-risk patients. Anesthesiology 99 (2003) 314-323
93. Landoni G., Fochi O., and Torri G. Cardiac protection by volatile anaesthetics: a review. Curr Vasc Pharmacol 6 (2008) 108-111
94. Conzen P.F., Fischer S., Detter C., and Peter K. Sevoflurane provides greater protection to the myocardium than propofol in patients undergoing off-pump coronary artery bypass surgery. Anesthesiology 99 (2003) 833
95. Yu C.H., and Beattie W.S. The effects of volatile anesthetics on cardiac ischemic complications and mortality in CABG: a meta-analysis. Can J Anaesth 53 (2006) 906-918
96. Hausenloy D.J., and Yellon D.M. Remote ischaemic preconditioning: underlying mechanisms and clinical application. Cardiovasc Res 79 (2008) 377-386
97. Przyklenk K., Bauer B., Ovize M., Kloner R.A., and Whittaker P. Regional ischemic 'preconditioning' protects remote virgin myocardium from subsequent sustained coronary occlusion. Circulation 87 (1993) 893-899
98. Pell T.J., Baxter G.F., Yellon D.M., and Drew G.M. Renal ischemia preconditions myocardium: role of adenosine receptors and ATP-sensitive potassium channels. Am J Physiol 275 (1998) H1542-H1547
99. Gho B.C., Schoemaker R.G., van den Doel M.A., Duncker D.J., and Verdouw P.D. Myocardial protection by brief ischemia in noncardiac tissue. Circulation 94 (1996) 2193-2200
100. Birnbaum Y., Hale S.L., and Kloner R.A. Ischemic preconditioning at a distance: reduction of myocardial infarct size by partial reduction of blood supply combined with rapid stimulation of the gastrocnemius muscle in the rabbit. Circulation 96 (1997) 1641-1646
101. Kharbanda R.K., Mortensen U.M., White P.A., Kristiansen S.B., Schmidt M.R., Hoschtitzky J.A., Vogel M., Sorensen K., Redington A.N., and MacAllister R. Transient limb ischemia induces remote ischemic preconditioning in vivo. Circulation 106 (2002) 2881-2883
102. Cheung M.M., Kharbanda R.K., Konstantinov I.E., Shimizu M., Frndova H., Li J., Holtby H.M., Cox P.N., Smallhorn J.F., Van Arsdell G.S., and Redington A.N. Randomized controlled trial of the effects of remote ischemic preconditioning on children undergoing cardiac surgery: first clinical application in humans. J Am Coll Cardiol 47 (2006) 2277-2282
103. Hausenloy D.J., Mwamure P.K., Venugopal V., Harris J., Barnard M., Grundy E., Ashley E., Vichare S., Di Salvo C., Kolvekar S., Hayward M., Keogh B., MacAllister R.J., and Yellon D.M. Effect of remote ischaemic preconditioning on myocardial injury in patients undergoing coronary artery bypass graft surgery: a randomised controlled trial. Lancet 370 (2007) 575-579
104. Ali Z.A., Callaghan C.J., Lim E., Ali A.A., Nouraei S.A., Akthar A.M., Boyle J.R., Varty K., Kharbanda R.K., Dutka D.P., and Gaunt M.E. Remote ischemic preconditioning reduces myocardial and renal injury after elective abdominal aortic aneurysm repair: a randomized controlled trial. Circulation 116 (2007) I98-105
105. Zhao Z.Q., Corvera J.S., Halkos M.E., Kerendi F., Wang N.P., Guyton R.A., and Vinten-Johansen J. Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning. Am J Physiol Heart Circ Physiol 285 (2003) H579-H588
106. Thibault H., Piot C., Staat P., Bontemps L., Sportouch C., Rioufol G., Cung T.T., Bonnefoy E., Angoulvant D., Aupetit J.F., Finet G., Andre-Fouet X., Macia J.C., Raczka F., Rossi R., Itti R., Kirkorian G., Derumeaux G., and Ovize M. Long-term benefit of postconditioning. Circulation 117 (2008) 1037-1044
107. Luo W., Li B., Lin G., and Huang R. Postconditioning in cardiac surgery for tetralogy of Fallot. J Thorac Cardiovasc Surg 133 (2007) 1373-1374
108. Luo W., Li B., Lin G., Chen R., and Huang R. Does cardioplegia leave room for postconditioning in paediatric cardiac surgery?. Cardiol Young 18 (2008) 282-287
109. Luo W., Li B., Chen R., Huang R., and Lin G. Effect of ischemic postconditioning in adult valve replacement. Eur J Cardiothorac Surg 33 (2008) 203-208
110. Sivaraman V., Mudalgiri N.R., Di Salvo C., Kolvekar S., Hayward M., Yap J., Keogh B., Hausenloy D.J., and Yellon D.M. Postconditioning protects human atrial muscle through the activation of the RISK pathway. Basic Res Cardiol 102 (2007) 453-459
111. Faggian G., Forni A., and Mazzucco A. Donor organ preservation in high-risk cardiac transplantation. Transplant Proc 36 (2004) 617-619
112. Ambros J.T., Herrero-Fresneda I., Borau O.G., and Boira J.M. Ischemic preconditioning in solid organ transplantation: from experimental to clinics. Transpl Int 20 (2007) 219-229
113. Karck M., Rahmanian P., and Haverich A. Ischemic preconditioning enhances donor heart preservation. Transplantation 62 (1996) 17-22
114. Lauzier B., Sicard P., Bouchot O., Delemasure S., Menetrier F., Moreau D., Vergely C., and Rochette L. After four hours of cold ischemia and cardioplegic protocol, the heart can still be rescued with postconditioning. Transplantation 84 (2007) 1474-1482
115. Konstantinov I.E., Li J., Cheung M.M., Shimizu M., Stokoe J., Kharbanda R.K., and Redington A.N. Remote ischemic preconditioning of the recipient reduces myocardial ischemia-reperfusion injury of the denervated donor heart via a Katp channel-dependent mechanism. Transplantation 79 (2005) 1691-1695
116. Jamieson R.W., and Friend P.J. Organ reperfusion and preservation. Front Biosci 13 (2008) 221-235
117. Szmagala P., Morawski W., Krejca M., Gburek T., and Bochenek A. Evaluation of perioperative myocardial tissue damage in ischemically preconditioned human heart during aorto coronary bypass surgery. J Cardiovasc Surg (Torino) 39 (1998) 791-795
118. Wu Z.K., Tarkka M.R., Eloranta J., Pehkonen E., Laurikka J., Kaukinen L., Honkonen E.L., Vuolle M., and Kaukinen S. Effect of ischaemic preconditioning, cardiopulmonary bypass and myocardial ischaemic/reperfusion on free radical generation in CABG patients. Cardiovasc Surg 9 (2001) 362-368
119. Laurikka J., Wu Z.K., Iisalo P., Kaukinen L., Honkonen E.L., Kaukinen S., and Tarkka M.R. Regional ischemic preconditioning enhances myocardial performance in off-pump coronary artery bypass grafting. Chest 121 (2002) 1183-1189
120. Wu Z.K., Laurikka J., Saraste A., Kyto V., Pehkonen E.J., Savunen T., and Tarkka M.R. Cardiomyocyte apoptosis and ischemic preconditioning in open heart operations. Ann Thorac Surg 76 (2003) 528-534
121. Wu Z.K., Vikman S., Laurikka J., Pehkonen E., Iivainen T., Huikuri H.V., and Tarkka M.R. Nonlinear heart rate variability in CABG patients and the preconditioning effect. Eur J Cardiothorac Surg 28 (2005) 109-113
122. Codispoti M., Sundaramoorthi T., Saad R.A., Reid A., Sinclair C., and Mankad P. Optimal myocardial protection strategy for coronary artery bypass grafting without cardioplegia: prospective randomised trial. Interact Cardiovasc Thorac Surg 5 (2006) 217-221
123. Ji B., Liu M., Liu J., Wang G., Feng W., Lu F., and Shengshou H. Evaluation by cardiac troponin I: the effect of ischemic preconditioning as an adjunct to intermittent blood cardioplegia on coronary artery bypass grafting. J Card Surg 22 (2007) 394-400
124. Mentzer Jr. R.M., Birjiniuk V., Khuri S., Lowe J.E., Rahko P.S., Weisel R.D., Wellons H.A., Barker M.L., and Lasley R.D. Adenosine myocardial protection: preliminary results of a phase II clinical trial. Ann Surg 229 (1999) 643-649
125. Teoh L.K., Grant R., Hulf J.A., Pugsley W.B., and Yellon D.M. The effect of preconditioning (ischemic and pharmacological) on myocardial necrosis following coronary artery bypass graft surgery. Cardiovasc Surg 53 (2002) 175-180
126. Shalaby A., Rinne T., Jarvinen O., Saraste A., Laurikka J., Porkkala H., Saukko P., and Tarkka M. Initial results of a clinical study: adenosine enhanced cardioprotection and its effect on cardiomyocytes apoptosis during coronary artery bypass grafting. Eur J Cardiothorac Surg 33 (2008) 639-644
127. Ranasinghe A.M., Quinn D.W., Pagano D., Edwards N., Faroqui M., Graham T.R., Keogh B.E., Mascaro J., Riddington D.W., Rooney S.J., Townend J.N., Wilson I.C., and Bonser R.S. Glucose-insulin-potassium and tri-iodothyronine individually improve hemodynamic performance and are associated with reduced troponin I release after on-pump coronary artery bypass grafting. Circulation 114 (2006) I245-I250
128. Alexander J.H., Emery Jr. R.W., Carrier M., Ellis S.J., Mehta R.H., Hasselblad V., Menasche P., Khalil A., Cote R., Bennett-Guerrero E., Mack M.J., Schuler G., Harrington R.A., and Tardif J.C. Efficacy and safety of pyridoxal 5′-phosphate (MC-1) in high-risk patients undergoing coronary artery bypass graft surgery: the MEND-CABG II randomized clinical trial. JAMA 299 (2008) 1777-1787
129. Symons J.A., and Myles P.S. Myocardial protection with volatile anaesthetic agents during coronary artery bypass surgery: a meta-analysis. Br J Anaesth 97 (2006) 127-136
130. Gunaydin B., Cakici I., Soncul H., Kalaycioglu S., Cevik C., Sancak B., Kanzik I., and Karadenizli Y. Does remote organ ischaemia trigger cardiac preconditioning during coronary artery surgery?. Pharmacol Res 41 (2000) 493-496